Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Am J Surg. 2016 Jan 9;212(2):297–304. doi: 10.1016/j.amjsurg.2015.10.030

Table 3.

Adherence to generic surgical process of care guidelines in non-Hispanic White and American Indian/Alaska Native patients.

GENERIC PROCESS MEASURES a Percent adherence
in NHW b, %
n=6022		 Percent adherence
in AI/AN c, %
n=154		 p-value d
If DM,e check glucose perioperatively 80.7 77.8 0.67
If on beta-blocker, order postop 93.9 85.0 0.13
Prophylactic antibiotics at incision 99.3 100.0 0.40
Pathology: margins reported 85.8 85.9 0.55
Mean adherence across
general process measures f (95% CI) 		91.9%
(91.4% – 92.3%)		 91.5%
(88.1% – 95.9%)		 0.57 g
a

. Process measures were evaluated for all non-Hispanic White and American Indian/Alaska Native patients who received inpatient operations for the 10 cancers listed in Table 1.

b

. NHW: non-Hispanic White.

c

. AI/AN: American Indian and Alaska Native.

d

. Reported as Fisher's exact test for difference in frequency between non-Hispanic Whites and American Indians/Alaska Natives unless otherwise stated.

e

. DM: diabetes mellitus

f

. Percentage adherence calculated across metrics for which a patient was eligible (e.g., patients who were not prescribed beta blockers were not eligible for beta-blocker continuation).

g

. Reported as two-sample Wilcoxon rank-sum (Mann-Whitney) test for differences.